On day three of the case brought before Delaware court by Ron Burkle’s Yucaipa challenging Barnes & Noble’s poison pill, testimony from expert witnesses finally delved into what’s been openly speculated about for months: if Burkle is able to wage the proxy fight he wants at the upcoming annual meeting this fall, it would hinge on an alliance between Yucaipa, and its more than 19% stake in BN, and the next-largest stockholder, money management firm Aletheia Research & Management, with a more than 16% stake in the company. Testifying on behalf of Yucaipa, CEO of MacKenzie Partners Inc. Daniel Burch […]
